IHS Chemical Week

World News and Views :: Top of the News

Merck KGaA terminates license agreement with Japanese pharma producer

8:21 AM MDT | June 17, 2014 | Natasha Alperowicz

Merck KGaA announced today that it has reached a mutual agreement with Ono Pharmaceutical (Osaka) to terminate a license agreement for ceralifimod (ONO-4641) because it does not meet Merck’s threshold for continued investment. Merck obtained the worldwide, exclusive license rights from Ono Pharmaceutical for the development and commercialization of ONO-4641 in multiple sclerosis (MS) outside of Japan, Korea, and Taiwan in October 2011. The drug candidate is currently in phase-two clinical development.   Merck says its biopharmaceutical division, Merck...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa